DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20190523

A clinical study of maternal outcome among pregnant mothers suffering from preeclampsia with thrombocytopenia

Kavyashree H. S., Rajeshwari K.

Abstract


Background: The thrombocytopenia in preeclampsia is mild to moderate, but severe thrombocytopenia can occur. Patients with eclampsia were at even greater risk for developing severe thrombocytopenia. And more likely to have HELLP syndrome, which is a subset of preeclampsia. Thrombocytopenia is a key and necessary component of this syndrome. The objective of the present study was to observe a clinical study of maternal outcome among pregnant mothers suffering from preeclampsia with thrombocytopenia.

Methods: A Hospital based Study was conducted at Mysore Medical College from January 2018 to December 20180 in the department of Obstetrics and gynecology. A total of 100 cases of Pregnancy from the records / case sheets of pregnant women with pregnancy induced hypertension admitted in the labor ward of the department of obstetrics and gynecology, Mysore Medical College, Mysore, Karnataka, India.

Results: Majority of the study subjects in present study were aged between 21-25 years (42%) followed by <20 years (26%). Nearly 55% of the study group were prim parous. In the above table out of 100 cases included in the study, 28 and 40 cases presented with mild and severe pregnancy induced hypertension, 8 cases were diagnosed as eclampsia and 24 cases presented with HELLP syndrome. The association between the mode of delivery and the variants of PIH was found to be statistically not significant. The Association between Mode of delivery and gestation weeks among the eclampsia cases was found to be not significant.

Conclusions: Thrombocytopenia in pregnancy induced hypertension carries a risk for both the mother and her fetus. The associated causes like abruption, retain dead fetus, septicemia and disseminated intravascular coagulation aggravates the complication for thrombocytopenia.


Keywords


Eclampsia, Maternal outcome, PIH, Pregnancy, Thrombocytopenia

Full Text:

PDF

References


McCrae KR, Samuel P, Schrciber AD. Pregnancy associated Thrombo-cytopenia: pathogenesis and management blood 1992;80;2697-2714.

Lee GR, Frester J, Wintrobes JL. Clinical hematology Vol.2, 10th edition; 1999.p.1579-1582.

Menell JS, Bursel JB. Antenatal Management of the thrombocyto-penias. Clin Perinatol. 1994; 21(3):591-614.

Charo IF, Kieffer N, Philips DR. Platelet membrane glycoproteins. Hemostasis and thrombin; basic principles and clinical practice, Philadelphia, PA: JB Lippincott Co.; 1994.p.489-507.

Greer IA, Walker JJ, Cameron AD, McLaren M, Calder AA, Forbes CD. A prospective longitudinal study of immunoreactive prostacyclin and TxA2 metabolites in normal and hypertensive pregnancy. Clin Exp Hypertens 1985; B4(2-3);167-82.

Robert S Egerman and Baha M Sibai, Clinical Obstetrics and Guynaecology Vol 42. No. 2 Page 381-9.

Spellacy W N, Handler A, Ferre C D. a case control study of 1253 twin pregnancies from 1982 to 1987. Perinatal data base 1990;75:198- 201.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III. LC, Wenstrm KD. Hypertensive disorders in pregnancy. Ch 37 In William Obstetrics. 21st ed. Mc Graw Hill Company; 2002:871-907.

Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB et al. Pregnancy Outcomes in Healthy Nulliparas Who Developed Hypertension. Obstet Gynecol. 2000;95(1):24-28.

Ray JG, Vermeulen MJ, Burrows EA, Burrows RF. Use of antihypertensive medications in Pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension in Pregnancy 2 (MOS HIP 2). BMC Pregnancy and ChildBirth 2001;1(1):6.

Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol. 1990;163(4):1147-50.

Kenton JG. The serological investigation of patients with autoimmune thrombocytopenia. Thromb Hoemost 1995;74(1):228-33.

Joshi SR, Tekwani DT, Bihade A, Joshi R, Murley D. Study of coagulation profile in pregnancy induced hypertension at MIMER Medical College, Talegaon, Dabhade. MedPulse – International Medical Journal. 2015;2(1):299-302.

Saphier CJ, Repke JT. Haemolysis elevated liver enzymes and low platelet count (HELLP) syndrome; a review of diagnosis and management. Semen Perinatol 1998;22(2):118.

Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated HELLP syndrome subsequent pregnancy outcomes long term prognosis. Am J Obstet Gynaecol. 1995;172(1):125-9.

Martin JN Jr, Rinehart B, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol 1999; 180(6):1373-84.

Sibai BM, Ramadan MK, Usta I, Salama M. Maternal Mortality and Morbidity in 442 Pregnancies with HELLP syndrome. Am. J. Obstet Gynecol. 1993;169(4):1000-06.